| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.48 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |